"The technology we have is nothing original. It is just one of the many ADCs out there," said Ko Han-sung, chairman of the Korea Biotechnology Industry Organization.
Ko said AI has made even fundraising difficult for biotech companies.
"I would be grateful if those in government could understand our pain and hardship, and bring about changes we can tangibly feel," he said.
Lee Min-woo, acting deputy minister for industry and growth at the Ministry of Trade, Industry and Resources, pledged to sharply expand the ministry's support for the bio industry. He said the ministry would focus on stabilizing supply chains for bio materials, parts and equipment.
The three-day event runs under the theme "Real Innovation Glows in the Dark" and has drawn more than 300 companies from around the world with about 600 booths.
More than 90 speakers will appear across 30 conference sessions on topics from AI-driven drug discovery to radiopharmaceuticals.
Canada is this year's country of honor, sending a delegation of about 30 biotech and healthcare companies to showcase their technologies at a dedicated Canada Pavilion.
Stuart Cable, global head of M&A at U.S. law firm Goodwin, headlines Thursday with a keynote titled "When Big Pharma Comes Knocking."
The event closes Friday with a live brain-computer interface demonstration by Dion Kelly of Possibility Neurotechnologies.
AJP Takeaways
- BIX 2026, a biotech convention co-hosted by the Korea Biotechnology Industry Organization and RX Korea, opened on Oct. 28, 2026, at COEX in Seoul and runs through Oct. 30.
- More than 300 companies are taking part with about 600 booths, and more than 90 speakers will appear across 30 conference sessions.
- The Ministry of Trade, Industry and Resources pledged to expand support for the bio industry, with a focus on stabilizing supply chains for bio materials, parts and equipment.
Copyright ⓒ Aju Press All rights reserved.